Pregnancy-related maternal physiological adaptations and fetal chemical exposure
Open accessAbstract
Prenatal life represents a susceptible window of development during which chemical exposures can permanently alter fetal development, leading to an increased likelihood of disease later in life. Therefore, it is essential to assess exposure in the fetus. However, direct assessment in human fetuses is challenging, so most research measures maternal exposure. Pregnancy induces a range of significant physiological changes in women that may affect chemical metabolism and responses. Moreover, placental function, fetal sex, and pregnancy complications may further modify these exposures. The purpose of this narrative review is to give an overview of major pregnancy-related physiological changes, including placental function and impacts of pregnancy complications, to summarize existing studies assessing chemical exposure in human fetal organs, and to discuss possible interactions between physiological changes and exposures. Our review reveals major knowledge gaps in factors affecting fetal chemical exposure, highlighting the need to develop more sophisticated tools for chemical health risk assessment in fetuses.
AI snapshot
Written from the paper’s full text.
TL;DR
This narrative review argues that pregnancy-related maternal physiological adaptations, placental function, fetal sex, and pregnancy complications can modify fetal chemical exposure, but direct human fetal exposure data remain sparse. It synthesizes maternal/placental physiology and human fetal tissue studies to highlight major knowledge gaps for fetal chemical risk assessment.
Key findings
- Pregnancy induces major cardiovascular, renal, metabolic, endocrine, and immune changes—e.g., cardiac output increases by 30–50% and GFR increases by more than 50%—which may alter chemical absorption, distribution, metabolism, and excretion, thereby influencing fetal exposure.
- Placental function and fetal sex modify exposure: placental insufficiency, gestational diabetes, and hypertensive disorders alter placental structure/transport; one study found the highest exposures in full-term pregnancies with male fetuses and normally functioning placentas, and lipophilic pollutants accumulated in fetal adipose tissue up to 100-fold higher than in placental tissue.
- Human fetal tissue studies show chemicals cross the placenta and deposit in vital organs; detected chemicals include organochlorine pesticides, PCBs, PBDEs, PFAS, organophosphate pesticides, and bisphenol A, with reported concentrations ranging from not detected to μg-ng/g (ppm-ppb) and high inter-individual variation. The largest study included 85 fetuses, and the median sample size was 44.
- Knowledge gaps remain: only 500 of 100,000 chemicals on the EU market have been thoroughly risk assessed, the world market is estimated at approximately 350,000 chemicals, and common pregnancy complications—gestational diabetes at 14% and hypertensive disorders at 10%—are often excluded from studies.
Methods
- Narrative review; no primary data. It synthesizes literature on maternal physiological adaptations in normal and complicated pregnancy, placental development and function, human fetal chemical exposure studies, and in silico pregnancy physiologically based pharmacokinetic/toxicokinetic (p-PBPK/PBTK) models.
- For fetal exposure, it reviews studies in Table 1 measuring industrial chemical residues in human fetal and neonatal tissues from elective pregnancy terminations, stillbirths, and perinatal autopsies, mostly from North America and Europe.
- Main analysis is qualitative synthesis; no systematic search strategy or meta-analysis is described.
Limitations
- The paper states major knowledge gaps: factors affecting fetal chemical exposure are poorly understood; fetal tissue studies have small sample sizes, cover limited chemicals and geographic regions, and p-PBPK models face validation challenges; causality is difficult to establish from epidemiological associations.
- The paper notes that fetal tissue studies rely on non-viable pregnancies (terminations, stillbirths, neonatal deaths), often with anonymized samples and limited maternal/fetal data, and that analytical methods have changed markedly over half a century, limiting comparability.
- Evident from the text: as a narrative review, it does not report a systematic search or formal quality assessment, and the reviewed studies are heterogeneous in design, tissues, chemicals, and reporting.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
39 of 79 cited sources checked · 17 supported · 1 flagged · accuracy not yet measured
- Premisecitation§ 1.1. Exposure to human-made chemicals is common · p. 1
Mixtures of industrial chemical residues are commonly present in the blood and urine of diverse populations.
“Multiple biomonitoring studies have found that mixtures of industrial chemical residues are commonly present in the blood and urine of diverse populations (Crinnion, 2010; Porta et al., 2008; Dominguez-Romero et al., 2023; Tkalec et al., 2022; Woodruff et al., 2011).”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites Crinnion, 2010
- cites Porta et al., 2008 source
- cites Dominguez-Romero et al., 2023 source
The Introduction (page unavailable) reports that phthalates were detected in more than 90% of urine samples from general populations in Asian, European, and North American countries. The paper also analyzes urinary metabolites of several phthalates and substitutes, but it does not establish that mixtures of industrial chemical residues are commonly present in blood. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation§ 1.3. Assessing chemical risks in the fetus is challenging · p. 2
Concentrations of persistent EDCs between fetal organs differed by several orders of magnitude.
“Furthermore, concentrations between fetal organs also differed by several orders of magnitude (Bjorvang et al., 2021).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Bjorvang et al., 2021 source
Section 3.3 reports distinct concentration patterns across fetal organs, with the highest tissue-to-serum ratios in adipose tissue and the lowest among fetal organs in the brain. But the reported ranges do not establish that concentrations between fetal organs generally differed by several orders of magnitude. Section 3.6 gives total burdens of 40,000 pg/g in adipose tissue and 1,100 pg/g in brain—about a 36-fold difference. (LLM, conf=0.82)
Experimental — accuracy not yet measured
- Premisecitation§ 3.6. Altered placental function · p. 7
Inadequate placentation is seen in several common obstetrical syndromes, including fetal growth restriction, spontaneous second trimester miscarriages, placental abruption, preterm birth, and hypertensive disorders in pregnancy.
“Inadequate placentation is seen in several common obstetrical syn dromes, including fetal growth restriction, spontaneous second trimester miscarriages, placental abruption, preterm birth, and hyper tensive disorders in pregnancy (Brosens et al., 2011).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Brosens et al., 2011 source
- Premisecitation§ 3.6. Altered placental function · p. 7
As non-transformed arteries still constrict in response to vaso-constricting signals, there is a risk of ischemia-reperfusion damage to the villi.
“As the non-transformed arteries still constrict in response to vaso-constricting signals, there is also a risk of ischemia-reperfusion damage to the villi (Staff et al., 2022).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Staff et al., 2022 source
- Interpretationreasoning§ 3.4. Placental function by fetal sex · p. 6
The higher vulnerability in males and improved outcomes in females when the intrauterine milieu changes and becomes less hospitable is most likely explained by sex differences in fetal growth strategy and reserve capacity.
“This most likely explains the higher vulnera bility in males and the improved outcomes in females seen when the intrauterine milieu changes and become less hospitable (Meakin et al., 2021; Teulings et al., 2020).”
Quote in the paperSubstantial claim2 of 2 sources checked- cites Meakin et al., 2021 source
- cites Teulings et al., 2020 source
The Conclusions (page unavailable) report a higher incidence of placenta-mediated pathologies in pregnancies with male rather than female fetuses, supporting the male-vulnerability part. The Discussion and Conclusions do not establish improved female outcomes when the intrauterine environment becomes less hospitable or explain the difference through fetal growth strategy and reserve capacity; the Discussion says the mechanism underlying the observed sex difference is unknown. (LLM, conf=0.82)
Experimental — accuracy not yet measured
- Premisecitation§ 1.3. Assessing chemical risks in the fetus is challenging · p. 2
The Caporale et al. (2022) study found that approximately half of the women were exposed to levels of chemicals that could compromise neurodevelopment in their child.
“The study found that approximately half of the women were exposed to levels of chemicals that could compromise neurodevelopment in their child.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Caporale et al., 2022 source
The available indexed passages are repository metadata, including a project listing under the label “Abstract,” rather than the paper’s findings. Searches for the claimed approximately half of women and for a 50% chemical-mixture exposure associated with child neurodevelopment found no passage addressing the estimate. The claim cannot be verified from our copy. (LLM, conf=0.72)
Experimental — accuracy not yet measured
- Premisecitation§ 1.3. Assessing chemical risks in the fetus is challenging · p. 2
The Caporale et al. study does not tell what levels of chemicals the developing fetal brains were actually exposed to because the exposure was estimated from levels of chemicals in maternal blood.
“However, the study does not tell what levels of chemicals the developing fetal brains were actually exposed to because the exposure was estimated from levels of chemicals in maternal blood.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Caporale et al., 2022 source
The indexed copy contains an IRIS repository record rather than passages describing the study’s exposure measurements; the “01 - Articolo su periodico” section lists a PDF but provides no methods or results (no page number). Searches for maternal-blood measurements and fetal-brain chemical concentrations found no passage establishing whether the study measured either, so the claim cannot be verified from this copy. (LLM, conf=0.73)
Experimental — accuracy not yet measured
- Findingcitation§ 4.1. Overview of literature on chemicals in human fetal tissues · p. 8
Most reported studies have focused on persistent chemicals.
“Most of the reported studies have focused on persistent chemicals, presumably because they are easier to measure in tissue samples (Table 1) (Bjorvang et al., 2021; Mamsen et al., 2017, 2019; Curley et al., 1969; Doucet et al., 2009; Nishimura et al., 1977; Pusiol et al., 2016; Rawn et al., 2014; Schecter et al., 2007; Zavon et al., 1969).”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites Bjorvang et al., 2021 source
- cites Mamsen et al., 2017, 2019
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Curley et al., 1969 source
- The authors state this as an assumption: Persistent chemicals are easier to measure in tissue samples than rapidly metabolized chemicals.
- Findingcitation§ Table 1 · p. 10
A study from our group found significant effects of gestational length, fetal sex, and placental function on chemical levels in fetuses.
“A study from our group, focusing on persistent organic pollutants in multiple fetal tissues from cases of intrauterine fetal death in the third trimester of pregnancy, found sig nificant effects of gestational length, fetal sex, and placental function on chemical levels in the fetuses (Bjorvang et al., 2021).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Bjorvang et al., 2021 source
- Premisecitation§ 4.2. Factors influencing fetal chemical exposure · p. 8
Many chemicals can be quite regionally produced and used.
“In addition, many chemicals can be quite regionally produced and used (Wang et al., 2020).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Wang et al., 2020 source
Section 3.1 finds that almost every country has significant numbers of chemicals registered only in that country, supporting the claim of regional differences. But Section 2.3 says registration may reflect production, import, or use and does not establish that a chemical is currently produced or used there. The evidence therefore does not fully support the claim about regional production and use. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation§ 4.2. Factors influencing fetal chemical exposure · p. 8
Pregnancy itself affects the expression of metabolic enzymes in the pregnant woman.
“However, pregnancy itself also affects the expression of metabolic enzymes in the pregnant woman (Fig. 1) (Koren et al., 2018; Isoherranen et al., 2013).”
Quote in the paperSubstantial claim1 of 2 sources checked - Interpretationreasoning§ Table 1 · p. 11
Considering that the world market is estimated to encompass approximately 350,000 chemicals, it is highly likely that the true intrinsic exposure of human fetuses to chemical residues is higher than suggested by studies in Table 1.
“Considering that the world market is estimated to encompass approximately 350 000 chemicals (Wang et al., 2020), it is highly likely that the true intrinsic exposure of human fetuses to chemical residues is higher than suggested by studies in Table 1.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Wang et al., 2020 source
- Findingcitation§ Table 1 · p. 10
Lipophilic organic pollutants, like organochlorine pesticides and PCB compounds, efficiently crossed the placenta and accumulated in fetal adipose tissue in up to 100-fold higher concentrations compared to placental tissue.
“We found that in particular the lipophilic organic pollut ants, like organochlorine pesticides and PCB compounds, efficiently crossed the placenta and accumulated in fetal adipose tissue in up to 100-fold higher concentrations compared to placental tissue.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Bjorvang et al., 2021 source
Section 3.2 reports that the studied chemicals reached fetal tissues from maternal circulation and accumulated especially in adipose tissue. Section 3.3 and the Fig. 3 caption report higher fetal adipose concentrations than placental concentrations, but the text does not establish the claimed upper limit of 100-fold relative to placenta. The numerical range given in section 3.3 is for adipose-to-serum ratios, not adipose-to-placenta ratios. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Findingcitation§ 4.1. Overview of literature on chemicals in human fetal tissues · p. 8
Bisphenol A and its conjugated metabolites have been measured in multiple studies.
“Nevertheless, bisphenol A and its conjugated metabolites have been measured in multiple studies (Nahar et al., 2013, 2015; Pusiol et al., 2016; Anderson et al., 2012; Cao et al., 2012; Faulk et al., 2015; Mos covitz et al., 2016; Zhang et al., 2011).”
Quote in the paperNot a substantial claim1 of 3 sources checked - Findingcitation§ Table 1 · p. 10
The highest exposures were present in full-term pregnancies with male fetuses and normally functioning placentas.
“We found that the highest exposures were present in full-term pregnancies with male fe tuses and normally functioning placentas (Bjorvang et al., 2021).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Bjorvang et al., 2021 source
- Premisecitation§ 5. Summary and future Directions · p. 11
Pregnancy-related complications are common.
“pregnancy complications are common; for example, gestational diabetes affects 14% of all pregnancies (Wang et al., 2022), and hypertensive pregnancy disorders 10% (Cameron et al., 2022).”
Quote in the paperSubstantial claim1 of 2 sources checked- cites Wang et al., 2022 source
- cites Cameron et al., 2022 source
The Results (Overall Trends in Hypertensive Disorders of Pregnancy; page unavailable) show that hypertensive disorders are common: in 2019, incidence was 83.9 per 1,000 live births in rural areas and 77.2 per 1,000 in urban areas. That supports the general point, but not the cited figure of 10% of all pregnancies; the study measured live births and reports rates closer to 8%. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Findingcitation§ 5. Summary and future Directions · p. 11
As shown by our earlier study, estimating fetal exposure based on maternal chemical concentration may give a misleading picture of the diversity and levels of chemicals in different fetal tissues.
“As shown by our earlier study, this may give a misleading picture of the diversity and levels of chemicals in the different fetal tissues (Bjorvang et al., 2021).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Bjorvang et al., 2021 source
- Rests on an assumption: Exposure in fetuses is typically only estimated based on concentration of chemicals in the mother.
- Findingcitation§ 4.3. In silico models of fetal exposure · p. 11
Our study on fetal exposure to PFAS found the highest exposure during mid-gestation.
“Interestingly, our study on fetal exposure to PFAS also found the highest exposure during mid-gestation (Mamsen et al., 2019).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Mamsen et al., 2019 source
Section 4.1 (page unavailable) reports that liver concentrations of PFOA and PFNA were highest in the second trimester. That supports a mid-gestation peak for those compounds in that organ, but not the broader claim that fetal PFAS exposure overall was highest then. Section 3.3 reports a slightly higher total PFAS burden in first-trimester lung (3.5 ng/g) than in second-trimester liver (3.4 ng/g). (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Findingnone given§ 4.1. Overview of literature on chemicals in human fetal tissues · p. 8
Actual chemical exposure in the human fetus has seldom been measured.
“Despite the known sensitivity of the human fetus to chemical disruption, and the central role of the prenatal environment in deter mining post-natal health, actual chemical exposure in the human fetus has seldom been measured (Table 1).”
Quote in the paperSubstantial claim - Findingnone given§ 4.1. Overview of literature on chemicals in human fetal tissues · p. 8
In elective pregnancy terminations, it is typically not known whether the conceptus would have developed normally or not.
“In the case of elective pregnancy terminations, it is typically not known whether the conceptus would have developed normally or not.”
Quote in the paperSubstantial claim - Findingreasoning§ 4.1. Overview of literature on chemicals in human fetal tissues · p. 8
Available studies on chemical exposure in human fetal tissues rely on tissue material derived from pregnancies that did not lead to viable birth.
“The available studies rely on tissue material derived from pregnancies that did not lead to viable birth.”
Quote in the paperSubstantial claim - Findingnone given§ Table 1 · p. 11
Studies so far cover only a limited number of chemicals.
“Studies so far cover only a limited number of chemicals.”
Quote in the paperSubstantial claim - Findingnone given§ 4.1. Overview of literature on chemicals in human fetal tissues · p. 8
Chemicals detected in human fetal organs include multiple organochlorine pesticides, polychlorinated biphenyls, polybrominated flame retardants, per- and polyfluoroalkyl substances, organophosphate pesticides, and bisphenol A.
“In summary, chemicals detected in human fetal organs include multiple organochlorine pesticides, polychlorinated biphenyls, poly brominated flame retardants, per- and polyfluoroalkyl substances, organophosphate pesticides, and bisphenol A (Table 1).”
Quote in the paperNot a substantial claim - Findingreasoning§ 4.3. In silico models of fetal exposure · p. 11
However, the conditions for developing a good PBPK model are seldom met.
“However, this is seldom the case.”
Quote in the paperNot a substantial claim - Findingreasoning§ 4.1. Overview of literature on chemicals in human fetal tissues · p. 8
Reported concentrations of chemicals in human fetal tissues tend to vary from not detected or not quantified to μg-ng/g (ppm-ppb) range.
“Nevertheless, the reported concentrations tend to vary from not detected or not quantified to μ g-ng/g (ppm-ppb) range (Table 1).”
Quote in the paperNot a substantial claim - Findingnone given§ 4.2. Factors influencing fetal chemical exposure · p. 8
Most studies on chemicals in human fetal tissues have been carried out in North America.
“Most of the studies on chemicals in human fetal tissues have been carried out in North America.”
Quote in the paperSubstantial claim - Findingnone given§ Table 1 · p. 10
A common denominator for fetal chemical exposure studies is relatively small sample size.
“A common denominator for fetal chemical exposure studies is rela tively small sample size.”
Quote in the paperNot a substantial claim - Findingreasoning§ Table 1 · p. 10
In most cases, the authors could not relate the inter-individual variation to fetal age and sex.
“In most cases, the authors could not relate the inter-individual variation to these factors.”
Quote in the paperNot a substantial claim - Findingreasoning§ 4.2. Factors influencing fetal chemical exposure · p. 8
Reports on chemical residues in human fetal tissues are rare outside North America and Europe.
“To the best of our knowledge, reports on chemical residues in human fetal tissues are rare outside North America and Europe.”
Quote in the paperSubstantial claim - Findingown data§ 5. Summary and future Directions · p. 11
Our studies have suggested that placental insufficiency may have a significant effect on fetal exposure.
“Our studies have suggested that placental insufficiency may have a signifi cant effect on fetal exposure.”
Quote in the paperNot a substantial claim - Premisecitation§ 1.1. Exposure to human-made chemicals is common · p. 1
Pregnancy induces significant physiological changes in women that may affect chemical metabolism and responses.
“Pregnancy induces a range of significant physiological changes in women that may affect chemical metabolism and responses.”
- Also stated in: § 2. Maternal physiological adaptation during pregnancy · p. 3 · plain
“During pregnancy, a woman undergoes significant anatomic and physiological changes in order to prepare her body for the exertions she is going to endure during pregnancy and delivery, and to optimize the growth and development of the fetus (Cunningham et al., 2022).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Cunningham et al., 2022
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Also stated in: § 2. Maternal physiological adaptation during pregnancy · p. 3 · plain
- Premisecitation§ 1.2. Fetal development is uniquely susceptible to chemical exposures · p. 2
Fetal development is a time particularly sensitive to chemical perturbations.
“The consequences of endocrine disruption can be particularly dire when exposure takes place prenatally, as fetal development is a time particularly sensitive to chemical perturbations (Ghassabian et al., 2022).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ghassabian et al., 2022 source
- Interpretationcitation§ 1.2. Fetal development is uniquely susceptible to chemical exposures · p. 2
Responses in fetuses cannot be reliably predicted from effects in adults.
“While chemical exposures affect health negatively even in adults, critically, the responses in fetuses cannot be reliably predicted from effects in adults.”
Quote in the paperSubstantial claim - Interpretationreasoning§ 3.6. Altered placental function · p. 6
Pathologies affecting placental growth, development, or premature deterioration influence placental function in a way that affects fetal exposure to EDCs.
“These pathologies influence the function of the organ in such a way that it also affects fetal exposure to EDCs.”
Quote in the paperSubstantial claim - Premisecitation§ 3.6. Altered placental function · p. 7
Hyperglycemia has been shown to decrease cytotrophoblast invasive ability, which is essential for the transformation of the spiral arteries and inadequate in placental dysfunction.
“However, hyperglycemia has also been shown to decrease the cyto trophoblasts invasive ability which is, as previously mentioned, essential for the transformation of the spiral arteries, and inadequate in placental dysfunction (Bedell et al., 2021).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Bedell et al., 2021 source
- Interpretationcitation§ 3.5. Placental imprinting · p. 6
EDCs could play a role in placental imprinting, thereby affecting placental function and fetal growth in humans.
“These observations suggest that EDCs could play a role in placental imprinting, thereby affecting placental function and fetal growth in humans.”
Quote in the paperSubstantial claim- Rests on an assumption: Placental function is regulated by imprinted genes.
- Rests on an assumption: Aberrations in imprinting can lead to abnormal fetal growth.
- Rests on an assumption: Imprinted genes are expressed in a parent-of-origin manner, with either the maternal or paternal allele silenced by DNA methylation.
- Rests on an assumption: IGF2 promotes both placental development and fetal growth.
- Premisecitation§ 2.6. The immune system and inflammation · p. 5
Pregnant women have altered capacity to metabolize, detoxify, and excrete chemicals and toxins.
“Pregnant women have altered capacity to metabolize, detoxify, and excrete chemicals and toxins (Koren et al., 2018).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Koren et al., 2018 source
- Premisecitation§ 3.5. Placental imprinting · p. 6
Imprinting defects in IGF2 are linked to fetal growth restriction.
“Imprinting defects in IGF2 have been linked to fetal growth restriction (Argyraki et al., 2019).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Argyraki et al., 2019 source
- Interpretationreasoning§ 3.6. Altered placental function · p. 8
Common pregnancy complications associated with altered placental function have an impact on fetal exposure to EDCs.
“These disor ders have an impact on fetal exposure to EDCs and thus it is of great importance to not only study normal and healthy pregnancies when trying to understand the impact of fetal EDC exposure on the offspring.”
Quote in the paperSubstantial claim - Premisecitation§ 4.1. Overview of literature on chemicals in human fetal tissues · p. 8
Even in the most thoroughly-studied cases, causes of fetal/neonatal death remain unestablished in about one fifth of cases.
“However, even in the most thoroughly-studied cases the causes remain unestablished in about one fifth of cases (Varli et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Varli et al., 2008 source
- Interpretationreasoning§ 3.6. Altered placental function · p. 7
A larger placenta, change of endocrine function, as well as change in placental transporters, most likely also affect the fetal exposure to environmental disruptors.
“A larger placenta, change of endocrine function, as well as change in placental transporters, most likely also affect the fetal exposure to environmental disruptors.”
Quote in the paperNot a substantial claim - Premisecitation§ 4.2. Factors influencing fetal chemical exposure · p. 8
Nahar et al. found no correlation between bisphenol A concentrations and expression of genes related to its metabolism in fetal livers.
“Nahar et al. found no correlation between bisphenol A concentrations and expression of genes related to its metabolism in fetal livers (Nahar et al., 2013, 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Nahar et al., 2013, 2015
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ 4.3. In silico models of fetal exposure · p. 11
A systematic literature summary catalogued 35 pregnancy-related anatomical, physiological and biochemical parameters relevant to p-PBPK models that should be considered.
“A systematic summary of literature to catalogue pregnancy-related anatomical, physiological and biochemical changes of relevance to p-PBPK models listed 35 different parameters that should be taken into consideration (Abduljalil et al., 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Abduljalil et al., 2012 source
- Interpretationreasoning§ 4.2. Factors influencing fetal chemical exposure · p. 8
The concentration of studies in North America and Europe biases the literature into regions with relatively progressive chemical legislation, work environment safety and environmental protection.
“This biases the studies into regions with relatively pro gressive chemical legislation, work environment safety and environ mental protection.”
Quote in the paperSubstantial claim - Premisecitation§ 4.1. Overview of literature on chemicals in human fetal tissues · p. 8
Analysis of bisphenol A by Cao et al. suggests an increasing trend over time.
“For example, analysis of bisphenol A by Cao et al. suggests an increasing trend over time (Cao et al., 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Cao et al., 2012 source
- Premisecitation§ 4.3. In silico models of fetal exposure · p. 11
The 35 parameters range from changes in organ size, blood volume and flow to plasma lipids, metabolic enzyme activities, and hormonal changes.
“These ranged from changes in organ size and blood volume and flow to plasma lipids, metabolic enzyme activities, and hormonal changes in line with the many significant changes known to take place in pregnancy (Fig. 1).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Abduljalil et al., 2012 source
- Premisecitation§ 4.1. Overview of literature on chemicals in human fetal tissues · p. 8
PFAS have been detected in all analyzed human fetuses.
“They are accompanied by the PFAS, which are an even more persistent family of chemicals, and have been also detected in all analyzed human fetuses (Mamsen et al., 2017, 2019).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Mamsen et al., 2017, 2019
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationcitation§ 4.2. Factors influencing fetal chemical exposure · p. 8
The correlations between MRP transporters and bisphenol A conjugates may suggest that phase II metabolism has a more important role in fetal liver chemical exposure than phase I metabolism.
“which may suggest that phase II metabolism has a more important role in fetal liver chemical exposure than phase I metabolism.”
Quote in the paperNot a substantial claim - Premisecitation§ 4.1. Overview of literature on chemicals in human fetal tissues · p. 8
DDT, its metabolites, and other similar chlorinated lipophilic chemicals such as polychlorinated biphenyl ethers were found in multiple tissues of fetuses that died in the womb.
“DDT, its metabolites, and other similar chlorinated lipophilic chemicals such as polychlorinated biphenyl ethers, were found in multiple tissues of fe tuses that died in the womb (Curley et al., 1969; Nishimura et al., 1977; Zavon et al., 1969).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Interpretationnone given§ 4.3. In silico models of fetal exposure · p. 11
p-PBPK models are not limited to predicting pharmaceutical toxicity and can be developed for any kind of chemicals, including EDCs.
“Although p-PBPK models have traditionally focused on modeling pharmacological agents, they are by no means limited to predicting pharmaceutical toxicity. Models can be developed for any kind of chemicals, including EDCs.”
Quote in the paperNot a substantial claim - Interpretationnone given§ 4.3. In silico models of fetal exposure · p. 11
The applicability domain of p-PBPK models can be quite narrow, reflecting only one family of chemicals.
“In addition, the applicability domain of the models can be quite narrow, only reflecting one (family of) chemical(s).”
Quote in the paperNot a substantial claim - Interpretationreasoning§ 5. Summary and future Directions · p. 11
Chemical exposures may contribute to the development of pregnancy disorders.
“chemical exposures may contribute to the development of pregnancy disorders.”
Quote in the paperSubstantial claim - Premisereasoning§ 5. Summary and future Directions · p. 12
These studies establish that chemicals pass through the placenta and deposit to vital organs of human fetuses.
“These studies establish that i) chemicals pass through the placenta and deposit to vital organs of human fetuses”
Quote in the paperSubstantial claim- Rests on an assumption: A handful of studies have measured chemical concentrations in human fetal tissues collected from elective pregnancy terminations or autopsies of stillborn infants.
- Interpretationreasoning§ 5. Summary and future Directions · p. 11
Pregnancy complications may alter fetal chemical exposures.
“pregnancy complications may alter fetal chemical exposures”
Quote in the paperSubstantial claim- Rests on an assumption: Pregnancy-related complications are always a risk factor to the mother and the fetus, leading to issues such as preterm birth, low birth weight, and even post-natal developmental aberrations.
- Premisecitation§ 4.3. In silico models of fetal exposure · p. 11
Some models for EDCs have already been developed.
“Some models for EDCs have already been developed.”
Quote in the paperNot a substantial claim
- Classified as probably not a substantial claim. 29
- May combine two claims. 38
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ 4.3. In silico models of fetal exposure · p. 11The Loccisano model considered the fetus as one compartment.
“The model considered the fetus as one compartment, and concluded that more studies are needed to better model the various factors affecting chem icals during pregnancy, such as possible changes in renal reabsorption of PFAS.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Loccisano et al., 2013 source
The Methods section (Gestation model–physiology; page not provided) explicitly describes three fetal compartments, contrary to the claim that the fetus was modeled as one compartment. The Discussion does call for more data on renal resorption, but that does not support the compartment claim. (LLM, conf=0.94)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
May combine two claims.
Premisecitation§ 3.4. Placental function by fetal sex · p. 6Fetuses of different sexes respond differently to changes in the intrauterine milieu: male fetuses prioritize growth, whereas female fetuses show increased adaptability and higher reserve capacity.
“In addition, fetuses of different sexes respond differently; while male fetuses prioritize growth, the females show increased adaptability and higher reserve capacity.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites Meakin et al., 2021 source
- cites Teulings et al., 2020 source
The Introduction and Discussion (Main findings; page numbers unavailable) describe sex differences in placental development and vascular resistance, supporting the general point that fetal sex matters. They do not say that males prioritize growth or that females have greater adaptability or reserve capacity; the reference title about growth and survival does not establish those specific claims. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
Premisecitation§ 3.6. Altered placental function · p. 7Gestational diabetes is associated with disorders of placental insufficiency, such as hypertension in pregnancy and stillbirth, which could be explained by endothelial dysfunction of women with the metabolic syndrome.
“Gestational diabetes is also associated with disorders of placental insufficiency, such as hypertension in pregnancy and stillbirth, which could be explained by the endothelial dysfunction of women with the metabolic syndrome (Rosenstein et al., 2012; Yang et al., 2022).”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites Rosenstein et al., 2012 source
The Comment section (page not provided) reports that women with gestational diabetes were more likely to experience stillbirth after 35 weeks. The paper does not establish an association with hypertension in pregnancy or identify placental insufficiency or endothelial dysfunction in metabolic syndrome as an explanation. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites Yang et al., 2022 source
The Mechanism and Predictive Markers section (Figure 1; page not provided) links gestational diabetes to placental ischemia, vascular endothelial injury, and preeclampsia with hypertension. The Introduction also describes an association between gestational diabetes and preeclampsia. The passages do not establish the claimed association with stillbirth or specifically explain these outcomes through endothelial dysfunction in women with metabolic syndrome. (LLM, conf=0.85)
Experimental — accuracy not yet measured
May combine two claims.
Premisecitation§ 3.6. Altered placental function · p. 7Gestational diabetes is associated with high aerobic fetal metabolism and hypoxia, stimulating the placenta to increase angiogenesis, resulting in increased number of capillaries; placentas also show abnormal endocrine function, increased inflammation, and changes in placental transporters.
“Gestational diabetes is associated with high aerobic fetal metabolism and hypoxia, stimulating the placenta to in crease angiogenesis, resulting in increased number of capillaries. The placentas also show abnormal endocrine function, increased inflam mation, and changes in placental transporters (Bedell et al., 2021; Denison et al., 2010; Gaither et al., 1999; Segura et al., 2017”
Quote in the paperSubstantial claim1 of 3 sources checkedMay combine two claims.
Interpretationcitation§ 3.4. Placental function by fetal sex · p. 5Placental differences dependent on fetal sex are numerous, and there are many mechanisms that could be involved in explaining how fetuses of different sexes are affected differently by prenatal EDC exposure.
“However, the placental differences dependent on fetal sex are numerous, and there are many mechanisms that could be involved in explaining how fetuses of different sexes are affected differently by prenatal EDC exposure (Braun et al., 2022).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Braun et al., 2022 source
The Background sections “The dynamic placental transcriptome” and “How does sex manifest in the human placenta?” describe numerous fetal-sex-dependent placental differences and potential mechanisms involving gene expression and hormones (page numbers unavailable). The passages do not connect those mechanisms specifically to differing fetal effects of prenatal endocrine-disrupting chemical (EDC) exposure. (LLM, conf=0.84)
Experimental — accuracy not yet measured
May combine two claims.
Premisecitation§ 3.4. Placental function by fetal sex · p. 5Throughout gestation placental function is influenced by fetal sex, resulting in sex-specific immunological and hormonal signaling, as well as sex-specific metabolism.
“Throughout gestation placental function is influenced by fetal sex, resulting in sex-specific immunological and hormonal signaling, as well as sex-specific metabolism (Braun et al., 2022).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Braun et al., 2022 source
May combine two claims.
Premisecitation§ 1.2. Fetal development is uniquely susceptible to chemical exposures · p. 2Exposure in utero to thalidomide caused severe malformations, and even fetal demise - effects that were not detected in the adult women taking the drug.
“Exposure in utero to thalidomide caused severe malformations, and even fetal demise - effects that were obviously not detected in the adult women taking the drug (Vargesson, 2015).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Vargesson, 2015 source
May combine two claims.
Premisecitation§ 3.6. Altered placental function · p. 6Limited trophoblast invasion leads to inadequate placentation and a shallow placenta, with less frequent transformation of peripheral and deeper myometrial parts of the spiral arteries and development of atherosis.
“A limited trophoblast invasion leads to inadequate placentation and a shallow placenta, with features illustrated in Fig. 3. The peripheral parts as well as the deeper myometrial parts of the spiral arteries are less often transformed and develop atherosis, a feature with many similar ities to atherosclerotic lesions (Pitz et al., 2021).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Pitz et al., 2021 source
The Acute Atherosis Etiology section (page unavailable) links poor spiral-artery remodeling to acute atherosis and says the lesions share morphological features with early atherosclerosis. It also says atherosis is mainly found downstream at the tips of decidual spiral arteries, whereas the major remodeling problems occur upstream in the myometrium; atherosis can occur without remodeling defects. The source therefore does not support the claim that the less-transformed peripheral and deeper myometrial parts themselves generally develop atherosis. (LLM, conf=0.87)
Experimental — accuracy not yet measured
May combine two claims.
Interpretationcitation§ 3.6. Altered placental function · p. 6Consequently, blood flows at a higher rate towards the villi, probably damaging the terminal branches, causing inflammation and stress later seen in the placenta, and likely playing a role in the development of maternal symptoms seen in hypertensive disorders in pregnancy.
“Consequently, the blood flows at a higher rate towards the villi, probably damaging the terminal branches, causing the inflammation and stress later seen in the placenta, likely playing a role in the development of the maternal symptoms seen in hypertensive disorders in pregnancy (Burton et al.,”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Burton et al., 2019 source
May combine two claims.
Premisecitation§ 3.5. Placental imprinting · p. 6Bisphenol A exposure is linked to altered methylation profiles in the human placenta and lower birth weight.
“Also, bisphenol A has been linked to altered methylation profiles in the human placenta, as well as lower birth weight (Nahar et al., 2015; Troisi et al., 2014).”
Quote in the paperSubstantial claim1 of 2 sources checkedMay combine two claims.
Findingcitation§ Table 1 · p. 10Concentrations in fetal tissues, normalized to maternal serum or placenta levels, were lower in pregnancies with female fetus, pregnancies with placental insufficiency, and pregnancies that ended earlier.
“The concentrations in fetal tissues, normalized to maternal serum or placenta levels, were lower in pregnancies with female fetus, pregnancies with placental insufficiency, and pregnancies that ended earlier (Bjorvang et al., 2021).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Bjorvang et al., 2021 source
Section 3.5 reports lower fetal tissue:maternal serum ratios with placental insufficiency, higher ratios for several chemicals in male than female fetuses, and positive associations between gestational age and several ratios during weeks 36–41. The comparisons by these three factors used maternal serum ratios, not tissue:placenta ratios, and the findings did not apply to every measured chemical or tissue. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
Premisecitation§ 4.2. Factors influencing fetal chemical exposure · p. 8Compared to adult liver, fetal liver is immature in its capacity to metabolize xenobiotics; it expresses a different set of xenobiotic-metabolizing enzymes, and the total amount of cytochrome P450 activity in fetal liver is significantly lower than in adult liver.
“Compared to adult liver, fetal liver is immature in its capacity to metabolize xenobiotics; it expresses a different set of xenobiotic-metabolizing enzymes, and the total amount of cytochrome P450 activity in fetal liver is significantly lower than in adult liver (Hakkola et al., 1998; Robinson et al., 2020).”
Quote in the paperSubstantial claim1 of 2 sources checkedMay combine two claims.
Premisecitation§ 4.1. Overview of literature on chemicals in human fetal tissues · p. 8Although DDT and PCBs have been globally restricted through the Stockholm Convention, they are still commonly detected in biomonitoring samples including human fetuses.
“Although DDT and PCBs have been globally restricted through the Stockholm Convention, they are still, half a cen tury later, commonly detected in biomonitoring samples including human fetuses (Bjorvang et al., 2021).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Bjorvang et al., 2021 source
May combine two claims.
Premisecitation§ 4.2. Factors influencing fetal chemical exposure · p. 8Zota et al. found a significant correlation between fetal liver burden of PBDE and expression of CYP1A1, but no correlation to any other studied CYPs.
“Zota et al. found significant correlation between fetal liver burden of PBDE and expression of CYP1A1 , but no correlation to any other studied CYPs (Zota et al., 2018).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Zota et al., 2018 source
The Results report a positive association between fetal-liver PBDE levels and CYP1A1 expression, but its 95% confidence interval in the full sample includes 1 (OR 2.36, 95% CI 0.98–5.68); it was significant in the analysis restricted to never-smokers. The Results also describe a suggestive, non-significant association with liver CYP2J2, so saying there was no correlation with any other studied CYP overstates the finding. Page numbers are unavailable in our copy. (LLM, conf=0.90)
Experimental — accuracy not yet measured
May combine two claims.
Findingcitation§ Table 1 · p. 10The largest study included 85 fetuses, while the median sample size of the reported studies was 44.
“The largest study included 85 fetuses (Zota et al., 2018), while the median sample size of the reported studies was 44 (Table 1).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Zota et al., 2018 source
The Study Population section reports two cohorts of 36 and 50 women, and the Cytochrome P450 mRNA expression section reports 84 fetal-liver samples examined. These passages establish a study of roughly the stated size but do not substantiate exactly 85 fetuses. The median of 44 is attributed to the citing paper’s Table 1, not to Zota et al. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ 4.3. In silico models of fetal exposure · p. 11The Loccisano model concluded that more studies are needed to better model factors affecting chemicals during pregnancy, such as possible changes in renal reabsorption of PFAS.
“The model considered the fetus as one compartment, and concluded that more studies are needed to better model the various factors affecting chem icals during pregnancy, such as possible changes in renal reabsorption of PFAS.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Loccisano et al., 2013 source
The Discussion (Gestation and Lactation Models; page not provided) calls for more kinetic data during pregnancy, including data on renal resorption of PFAAs, to improve model predictions. But the Methods (Gestation model–physiology; page not provided) describes fetal plasma, rest-of-body, and amniotic-fluid compartments—not the fetus as a single compartment. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ 5. Summary and future Directions · p. 11Hypertensive pregnancy disorders affect 10% of pregnancies.
“hypertensive pregnancy disorders 10% (Cameron et al., 2022)”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Cameron et al., 2022 source
The Methods and Results section (page unavailable) reports new-onset hypertensive disorders in 2019 at 83.9 per 1,000 rural live births and 77.2 per 1,000 urban live births—about 8%, not 10%. The study covers US live births, so it does not establish a 10% figure for pregnancies generally. (LLM, conf=0.84)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ 4.3. In silico models of fetal exposure · p. 11Loccisano et al. developed a human p-PBTK model for PFOS and PFOA based on earlier adult human models.
“For example, Loccisano et al. developed a human p-PBTK model for PFOS and PFOA based on earlier adult human models (Loccisano et al., 2013).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Loccisano et al., 2013 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingnone given§ 4.1. Overview of literature on chemicals in human fetal tissues · p. 8The method of pregnancy termination can vary from mechanical to pharmaceutical, and the possible impact of the method on chemicals in the collected samples has not been assessed.
“The method of pregnancy termination can vary from mechanical to pharmaceutical, and the possible impact of the method on chemicals in the collected samples has not been assessed.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone given§ 4.1. Overview of literature on chemicals in human fetal tissues · p. 8Samples representing the first half of pregnancy are often collected from elective pregnancy terminations, and studies covering the latter half are typically based on tissues collected during autopsies of stillborn infants and neonatal deaths.
“Samples representing the first half of pregnancy are often collected from elective pregnancy terminations, and the studies covering the latter half of the pregnancy are typically based on tissues collected during au topsies of stillborn infants and neonatal deaths (Table 1).”
Quote in the paperSubstantial claimMay combine two claims.
Findingnone given§ Table 1 · p. 10Half of the studies mentioned some maternal physiological factors, but their role in fetal exposure levels were considered only in a few studies.
“Half of the studies mentioned some maternal physiological factors, but their role in fetal exposure levels were considered only in a few studies.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone given§ Table 1 · p. 10Another common feature of fetal chemical exposure studies is the reported large variation between studied individual fetuses.
“Another common feature is the reported large variation between studied individual fetuses.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ 4.2. Factors influencing fetal chemical exposure · p. 8Older studies (1969-2007) were conducted with tissues collected from stillbirth and perinatal autopsies, covering the latter half of pregnancy and first weeks of life, whereas newer studies (2009-2018) focused on elective pregnancy terminations, primarily covering the first trimester.
“The older studies (1969 -2007) were conducted with tissues collected from stillbirth and perinatal autopsies, and therefore covered the latter half of pregnancy and the first weeks of life, whereas the newer studies (2009 -2018) focused on elective preg nancy terminations, primarily covering the first trimester of pregnancy (Table 1).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Findingreasoning§ 4.2. Factors influencing fetal chemical exposure · p. 8The most-often studied fetal organ is the liver.
“The most-often studied fetal organ is the liver.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone given§ Table 1 · p. 10In many cases, samples were anonymized and associated information was limited to fetal age and sex.
“In many cases, samples were ano nymized and associated information was limited to fetal age and sex (Table 1).”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone given§ 1.1. Exposure to human-made chemicals is common · p. 1Direct assessment of chemical exposure in human fetuses is challenging, so most research measures maternal exposure.
“However, direct assessment in human fetuses is challenging, so most research measures maternal exposure.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone given§ 1.1. Exposure to human-made chemicals is common · p. 1Placental function, fetal sex, and pregnancy complications may further modify fetal chemical exposure.
“Moreover, placental function, fetal sex, and pregnancy complications may further modify these exposures.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisecitation§ 1.1. Exposure to human-made chemicals is common · p. 1Prenatal life is a susceptible window of development during which chemical exposures can permanently alter fetal development, leading to an increased likelihood of disease later in life.
“Prenatal life represents a susceptible window of development during which chemical exposures can permanently alter fetal development, leading to an increased likelihood of disease later in life.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ghassabian et al., 2022 source
Probably not a substantial claim: may not pass S2 (checkable). May combine two claims.
Interpretationreasoning§ 1.1. Exposure to human-made chemicals is common · p. 1The review reveals major knowledge gaps in factors affecting fetal chemical exposure, highlighting the need to develop more sophisticated tools for chemical health risk assessment in fetuses.
“Our review reveals major knowledge gaps in factors affecting fetal chemical exposure, highlighting the need to develop more sophisticated tools for chemical health risk assessment in fetuses.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisecitation§ 3.6. Altered placental function · p. 7Gestational diabetes is characterized by increased insulin resistance and insufficient beta-cell insulin production.
“Another common pregnancy complication is gestational diabetes, characterized by increased insulin resistance and insufficient beta-cell insulin production (Szlapinski et al., 2021).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Szlapinski et al., 2021 source
May combine two claims.
Premisecitation§ 3.5. Placental imprinting · p. 6Maternal phthalate exposure is associated with imprinting of IGF2 in the placenta and low birth weight.
“Associations have been found between maternal phthalate exposure, imprinting of IGF2 in the placenta, and low birth weight (Zhao et al., 2015, 2016).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Zhao et al., 2015, 2016
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Interpretationreasoning§ 3.3. Placental bed barrier · p. 5As entire cells can pass the placental barrier, it is likely that EDCs pass the barrier too.
“As entire cells can pass the barrier, it is likely that EDCs pass the barrier too.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisecitation§ 3.1. Overview of placental formation · p. 5As the smooth muscle cells of the spiral arteries are replaced by trophoblasts, they become non-responsive to vasoconstricting substances, offering the fetus an unconditional supply of oxygen and nutrition, but also exposing it to other substances present in the maternal circulation.
“As the smooth muscle cells of the vessel walls are replaced by trophoblasts, they become non-responsive to vasoconstricting substances. This offers the fetus an unconditional supply of oxygen and nutrition, but also exposes it to other substances present in the maternal circulation (Cunningham, 2022).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Cunningham, 2022
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S4 (based).
Interpretationreasoning§ 2.6. The immune system and inflammation · p. 5Physiological (mal)adaptation is likely to alter the fetal chemical burden, adding a further layer of complexity to studies assessing associations between maternal chemical exposure and fetal development and post-natal health.
“In addition, physiological (mal)adaptation is likely to alter the fetal chemical burden, adding a further layer of complexity to studies assessing associations between maternal chemical exposure and fetal development and post-natal health.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Premisenone given§ 3. Placental development and function · p. 5The placenta plays a major role as a barrier, as well as enabling waste disposal, gas exchange, and nutrient supply.
“The placenta is one of the most essential maternal organs for the fetus, playing a major role as a barrier, as well as enabling waste disposal, gas exchange, and nutrient supply.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone given§ 1.4. New approaches in chemical safety assessment · p. 2Pregnancy complications widen the variation in physiological adaptations even more.
“In addition, pregnancy complications widen the variation even more.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationreasoning§ 1.3. Assessing chemical risks in the fetus is challenging · p. 2It is a challenge to demonstrate a causal mode of action in humans, and in practice data has to be collected by combining multiple lines of evidence.
“It is a challenge to demonstrate a causal mode of action in humans, and in practice data has to be collected by combining multiple lines of evidence.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone given§ 3.6. Altered placental function · p. 8Many pregnant women suffer from common pregnancy complications associated with altered placental function.
“In summary, many pregnant women suffer from common pregnancy complications associated with altered placental function.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationcitation§ 2.1. Adaptation and maladaptation in pregnancy · p. 4Overall, pregnant women are more sensitive to chemical exposure than non-pregnant women due to the physiological changes, more prone to develop pregnancy-related complications due to the exposure, and almost certainly even more vulnerable when pregnancy complications are already present.
“Overall, pregnant women are more sensitive to chemical exposure than non-pregnant women due to the physiological changes, more prone to develop pregnancy-related complications due to the exposure, and almost certainly even more vulnerable when pregnancy complications are already present (Gomez-Roig et al., 2021).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Gomez-Roig et al., 2021 source
May combine two claims.
Premisecitation§ 4.1. Overview of literature on chemicals in human fetal tissues · p. 8In fetal and neonatal deaths, causes of death may relate to severe malformations or chromosomal abnormalities, but are also often findings compatible with live births, such as placental insufficiency, intrauterine growth restriction, and infection.
“In the case of fetal and neonatal deaths, causes of death may relate to severe malformations or chromosomal abnormalities, but are also often findings that can be compatible with live births too, such as placental insufficiency, intrauterine growth re striction, and infection (Varli et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Varli et al., 2008 source
May combine two claims.
Interpretationreasoning§ 1.2. Fetal development is uniquely susceptible to chemical exposures · p. 2Developing organisms are uniquely susceptible to perturbations like chemical exposures, and protecting fetuses will require studies addressing toxicity specifically in fetuses.
“In summary, developing organisms are uniquely susceptible to perturbations like chemical exposures, and protecting fetuses will require studies addressing toxicity specifically in fetuses.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ 4.3. In silico models of fetal exposure · p. 11The systematic summary presented normal ranges of these parameters across normal pregnancy, excluding women with pregnancy-related complications or conditions.
“The ambitious work also presented the normal range of these parameters across normal pregnancy, excluding women with any pregnancy-related complications or conditions (Abduljalil et al., 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Abduljalil et al., 2012 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Interpretationreasoning§ 4.3. In silico models of fetal exposure · p. 11The accuracy of all PBPK models is highly dependent on the information that it is based upon.
“The accuracy of all PBPK models is highly dependent on the information that it is based upon.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone given§ 4.1. Overview of literature on chemicals in human fetal tissues · p. 8Varying storage conditions, the type of plastics and instruments used in sampling, or the laboratory environment as a whole are unlikely to significantly impact levels of persistent chemicals in the sample.
“In addition, varying storage conditions, the type of plastics and instruments used in sampling, or the laboratory environment as a whole are unlikely to significantly impact their levels in the sample.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationreasoning§ 4.1. Overview of literature on chemicals in human fetal tissues · p. 8More rapidly metabolized chemicals, like many plastic additives such as bisphenols and phthalates, are more difficult to capture due to their fast kinetics; their levels can vary widely depending on the environment and exposure of the subject on any given day.
“In contrast, more rapidly metabolized chemicals, like many plastic additives such as bisphenols and phthalates, are more difficult to capture due to their fast kinetics. Their levels can vary widely depending on the environment and expo sure of the subject on any given day.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationreasoning§ 4.1. Overview of literature on chemicals in human fetal tissues · p. 8Considering the continued growth of the chemical industry, the amount of chemicals the fetus is exposed to is likely to increase.
“Considering the continued growth of the chemical industry, both in terms of diversity and volume of chemicals, the amount of chemicals the fetus is exposed to is likely to increase.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationreasoning§ Table 1 · p. 11It is likely that differing placental vascular resistance between pregnancies with female and male fetuses, the impact of maternal pregnancy complications often present in cases of intrauterine fetal demise, as well as dysfunction of the vasculature in placental insufficiency, may have played a role in how fetal sex and placental function affected fetal organ exposure.
“However, it is likely that the differing placental vascular resistance between pregnancies with female and male fetuses, the impact of maternal pregnancy com plications that are often present in cases of intrauterine fetal demise, as well as the dysfunction of the vasculature in placental insufficiency, may have played a role (Figs. 2 and 3).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable).
Interpretationreasoning§ Table 1 · p. 11Factors such as maternal health and placental function should be taken into consideration when fetal chemical exposure is modelled.
“Nevertheless, when viewed together, these observations suggest that factors such as maternal health and placental function should be taken into consideration when fetal chemical exposure is modelled.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Interpretationreasoning§ 4.3. In silico models of fetal exposure · p. 11If the physicochemical properties of the chemical substance are well characterized, parameters affecting exposure as well as absorption, distribution, metabolism, and excretion are known, and accurate data on the concentration of the chemical in different compartments of the biological system is available for validation purposes, then it is likely that a good model can be developed.
“If the physicochemical properties of the chemical substance are well characterized, parameters affecting exposure as well as absorption, distribution, metabolism, and excretion are known, and accurate data on the concentration of the chemical in different compartments of the biological system (in this case: the preg nant woman) is available for validation purposes, then it is likely that a”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ 4.3. In silico models of fetal exposure · p. 11P-PBPK models were developed in the 1980s based on values measured in pregnant rodents, and human models started emerging a decade later.
“P-PBPK models were developed in the 1980s based on values measured in pregnant rodents, and human models started emerging a decade later (Lu et al., 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lu et al., 2012
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisereasoning§ 4.3. In silico models of fetal exposure · p. 11Since pregnancy causes substantial changes in physiology, specific PBPK models for pregnancy (p-PBPK models) have been developed.
“Since pregnancy causes substantial changes in physiology (Figs. 1 -2), specific PBPK models for pregnancy have been developed (so called p-PBPK models).”
Quote in the paperNot a substantial claim- Rests on an assumption: Pregnancy causes substantial changes in physiology.
Probably not a substantial claim: may not pass S3 (load-bearing).
Interpretationreasoning§ 4.3. In silico models of fetal exposure · p. 11Non-linear accumulation of chemicals to organs could depend on changes in fetal blood flow patterns during development.
“This non-linear accumulation of chemicals to organs could for example depend on changes in fetal blood flow patterns during development (Fig. 2).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ 4.3. In silico models of fetal exposure · p. 11Sharma et al. developed a p-PBPK model for bisphenol A where the fetal compartment also encompassed organs like brain, liver, and kidney.
“Sharma et al. developed a p-PBPK model for bisphenol A where the fetal compartment also encompassed organs like brain, liver, and kidney (Sharma et al., 2018).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sharma et al., 2018 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ 4.3. In silico models of fetal exposure · p. 11Validation of models on rapidly-metabolized compounds will remain challenging due to differing lifestyle variables just prior to sampling in biomonitoring studies and functional genetic variations in metabolizing enzymes in different populations.
“Although the model by Sharma showed good potential, the authors acknowledged that validation of models on rapidly-metabolized com pounds will remain challenging due not only to differing lifestyle vari ables just prior sampling in biomonitoring studies, but also functional genetic variations in metabolizing enzymes in different populations.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sharma et al., 2018 source
May combine two claims.
Premisecitation§ 5. Summary and future Directions · p. 11Exposure to adverse environments, such as malnutrition or toxic chemicals, can permanently shape the developing organs of the fetus, changing post-natal growth trajectory and conferring differing susceptibility to disease later in life.
“Exposure to adverse environments, be it malnutrition or toxic chemicals, can permanently shape the developing organs of the fetus in a way that changes post-natal growth trajectory and confers differing susceptibility to disease later in life.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Barker et al., 1986 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ 5. Summary and future Directions · p. 11Gestational diabetes affects 14% of all pregnancies.
“gestational diabetes affects 14% of all pregnancies (Wang et al., 2022)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wang et al., 2022 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Interpretationreasoning§ 4.3. In silico models of fetal exposure · p. 11The main challenge of human p-PBPK models is the validation process.
“The main challenge of the p-PBPK models in humans is the validation process.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ 4.3. In silico models of fetal exposure · p. 11The Sharma model predicted higher mid-gestation exposure in the fetal liver, in agreement with some observational studies.
“The model predicted higher mid-gestation exposure in the fetal liver in agreement with some observational studies.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sharma et al., 2018 source
May combine two claims.
Premisenone given§ 5. Summary and future Directions · p. 12These studies establish that variation in chemical concentration between individuals is very high and not often explained by gestational length or maternal exposure levels.
“ii) the variation in chemical concentration between individuals is very high, and not often explained by gestational length or maternal exposure levels.”
Quote in the paperSubstantial claim- Rests on an assumption: A handful of studies have measured chemical concentrations in human fetal tissues collected from elective pregnancy terminations or autopsies of stillborn infants.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ 5. Summary and future Directions · p. 11The concept of prenatal life as a defining, sensitive window of development has become well established since David Barker presented his hypothesis of adult heart disease being linked to poor nutrition during fetal development in the 1980s.
“Since David Barker presented his hypothesis of adult heart disease being linked to poor nutrition during fetal development in the 1980s, the concept of prenatal life as a defining, sensitive window of development has become well established (Barker et al., 1986).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Barker et al., 1986 source
The paper relies on this without support.
Placental function is regulated by imprinted genes.
“Placental function is also regulated by imprinted genes.”
The paper relies on this without support.
Aberrations in imprinting can lead to abnormal fetal growth.
“aberrations in imprinting can lead to abnormal fetal growth.”
The paper relies on this without support.
Imprinted genes are expressed in a parent-of-origin manner, with either the maternal or paternal allele silenced by DNA methylation.
“Their expression pattern is dictated in a parent-of-origin manner so that either the maternal or paternal allele is silenced by the epigenetic mechanism of DNA methylation.”
The paper relies on this without support.
IGF2 promotes both placental development and fetal growth.
“IGF2 - a growth factor which promotes both placental development and fetal growth.”
The paper relies on this without support.
Pregnancy causes substantial changes in physiology.
“Since pregnancy causes substantial changes in physiology (Figs. 1 -2)”
The authors state this as an assumption.
Persistent chemicals are easier to measure in tissue samples than rapidly metabolized chemicals.
“presumably because they are easier to measure in tissue samples”
The paper relies on this without support.
Pregnancy-related complications are always a risk factor to the mother and the fetus, leading to issues such as preterm birth, low birth weight, and even post-natal developmental aberrations.
“Pregnancy-related complications are always a risk factor to the mother and the fetus , leading to issues such as preterm birth, low birth weight, and even post-natal developmental aberrations.”
The paper relies on this without support.
Exposure in fetuses is typically only estimated based on concentration of chemicals in the mother.
“exposure in fetuses is typically only estimated based on concentration of chem icals in the mother.”
The paper relies on this without support.
Studies of chemical exposure during gestation tend to select 'normal healthy women' and uncomplicated pregnancies.
“There is a clear tendency to select ' normal healthy women ' and uncomplicated pregnancies when chemical exposures during gestation are studied.”
The paper relies on this without support.
The placenta is a crucial organ for both maternal and fetal health, and functional variations are common.
“The placenta is a crucial organ for both maternal and fetal health, and functional variations are common.”
The paper relies on this without support.
A handful of studies have measured chemical concentrations in human fetal tissues collected from elective pregnancy terminations or autopsies of stillborn infants.
“A handful of studies have measured chemical concentrations in human fetal tissues collected from elective pregnancy terminations or from autopsies of stillborn infants.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Studies include infants born alive despite the stated sample restriction
MinorThe text says the available tissue studies came from pregnancies without a viable birth, but Table 1 includes sudden infant deaths and samples from infants as old as 6.5 months postpartum.
“pregnancies that did not lead to viable birth.”
“| (Pusiol et al., 2016) | Intrauterine fetal death, sudden infant death Italy | N = 24 Age from gestational week 25 to 6.5 months post-partum”
Cites
INFANT MORTALITY, CHILDHOOD NUTRITION, AND ISCHAEMIC HEART DISEASE IN ENGLAND AND WALES
BARKER, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91340-1 · Cited by 2,892 · see citing works
EDC-2: the endocrine society's second scientific statement on endocrine-disrupting chemicals
Gore, A. C., Chappell, V. A., Fenton, S. E., Flaws, J. A., Nadal, A., Prins, G. S., Toppari, J., & Zoeller, R. T. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1010 · Cited by 2,407 · see citing works
McIntyre, H. D., Catalano, P., Zhang, C., Desoye, G., Mathiesen, E. R., & Damm, P. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0098-8 · Cited by 1,850 · see citing works
The “Great Obstetrical Syndromes” are associated with disorders of deep placentation
Brosens, I., Pijnenborg, R., Vercruysse, L., & Romero, R. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.08.009 · Cited by 1,568 · see citing works
Physiological changes in pregnancy
Soma-Pillay, P., Nelson-Piercy, C., Tolppanen, H., & Mebazaa, A. (2016) · Cardiovascular Journal of Africa · doi:10.5830/cvja-2016-021 · Cited by 1,483 · see citing works
State-of-the-science of endocrine disrupting chemicals, 2012
Bergman, Å., Heindel, J., Jobling, S., Kidd, K., & Zoeller, R. T. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.03.020 · Cited by 1,388 · see citing works
Wang, H., Li, N., Chivese, T., Werfalli, M., Sun, H., Yuen, L., Hoegfeldt, C. A., Elise Powe, C., Immanuel, J., Karuranga, S., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109050 · Cited by 1,260 · see citing works
Pre-eclampsia: pathophysiology and clinical implications
Burton, G. J., Redman, C. W., Roberts, J. M., & Moffett, A. (2019) · BMJ · doi:10.1136/bmj.l2381 · Cited by 1,250 · see citing works
Blencowe, H., Krasevec, J., de Onis, M., Black, R. E., An, X., Stevens, G. A., Borghi, E., Hayashi, C., Estevez, D., Cegolon, L., et al. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30565-5 · Cited by 1,242 · see citing works
Metabolism disrupting chemicals and metabolic disorders
Heindel, J. J., Blumberg, B., Cave, M., Machtinger, R., Mantovani, A., Mendez, M. A., Nadal, A., Palanza, P., Panzica, G., Sargis, R., et al. (2017) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.10.001 · Cited by 1,101 · see citing works
Wang, Z., Walker, G. W., Muir, D. C. G., & Nagatani-Yoshida, K. (2020) · Environmental Science & Technology · doi:10.1021/acs.est.9b06379 · Cited by 1,084 · see citing works
La Merrill, M. A., Vandenberg, L. N., Smith, M. T., Goodson, W., Browne, P., Patisaul, H. B., Guyton, K. Z., Kortenkamp, A., Cogliano, V. J., Woodruff, T. J., et al. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0273-8 · Cited by 1,005 · see citing works
Environmental chemicals in pregnant women in the United States: NHANES 2003–2004
Woodruff, T. J., Zota, A. R., & Schwartz, J. M. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002727 · Cited by 930 · see citing works
Thalidomide-induced Teratogenesis: History and Mechanisms
Vargesson, N. (2015) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.21096 · Cited by 912 · see citing works
Early Life Exposure to Endocrine Disrupting Chemicals and Childhood Obesity and Neurodevelopment
Braun, J. M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.186 · Cited by 837 · see citing works
Endocrine-disrupting chemicals: Implications for human health
Kahn, L. G., Philippat, C., Nakayama, S. F., Slama, R., & Trasande, L. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30129-7 · Cited by 797 · see citing works
Gore, A. C., Chappell, V. A., Fenton, S. E., Flaws, J. A., Nadal, Á., Prins, G. S., Toppari, J., & Zoeller, R. T. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1093 · Cited by 696 · see citing works
Cousins, I. T., Johansson, J. H., Salter, M. E., Sha, B., & Scheringer, M. (2022) · Environmental Science & Technology · doi:10.1021/acs.est.2c02765 · Cited by 624 · see citing works
Harrison, M. S., & Goldenberg, R. L. (2015) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2015.12.007 · Cited by 545 · see citing works
Environmental factors in declining human fertility
Skakkebæk, N. E., Lindahl-Jacobsen, R., Levine, H., Andersson, A.-M., Jørgensen, N., Main, K. M., Lidegaard, Ø., Priskorn, L., Holmboe, S. A., Bräuner, E. V., et al. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00598-8 · Cited by 389 · see citing works
The SLCO (former SLC21) superfamily of transporters
Hagenbuch, B., & Stieger, B. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.10.009 · Cited by 384 · see citing works
Abduljalil, K., Furness, P., Johnson, T. N., Rostami-Hodjegan, A., & Soltani, H. (2012) · Clinical Pharmacokinetics · doi:10.2165/11597440-000000000-00000 · Cited by 371 · see citing works
From cohorts to molecules: adverse impacts of endocrine disrupting mixtures
Caporale, N., Leemans, M., Birgersson, L., Germain, P.-L., Cheroni, C., Borbély, G., Engdahl, E., Lindh, C., Bressan, R. B., Cavallo, F., et al. (2022) · Science · doi:10.1126/science.abe8244 · Cited by 368 · see citing works
Self-citationFailure of physiological transformation and spiral artery atherosis: their roles in preeclampsia
Staff, A. C., Fjeldstad, H. E., Fosheim, I. K., Moe, K., Turowski, G., Johnsen, G. M., Alnaes-Katjavivi, P., & Sugulle, M. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.09.026 · Cited by 354 · see citing works
Mamsen, L. S., Björvang, R. D., Mucs, D., Vinnars, M.-T., Papadogiannakis, N., Lindh, C. H., Andersen, C. Y., & Damdimopoulou, P. (2019) · Environment International · doi:10.1016/j.envint.2019.01.010 · Cited by 338 · see citing works
Self-citationPathology of the Human Placenta
Benirschke, K. 1.-2., Kaufmann, P. 1.-2., & Baergen, R. N. (2006) · Springer eBooks · doi:10.1007/b137920 · Cited by 337 · see citing works
Consideration of pathways for immunotoxicity of per- and polyfluoroalkyl substances (PFAS)
Ehrlich, V. A., Bil, W., Vandebriel, R. J., Granum, B. B., Luijten, M., Lindeman, B., Grandjean, P., Kaiser, A.-M., Hauzenberger, I., Hartmann, C., et al. (2023) · Environmental Health · doi:10.1186/s12940-022-00958-5 · Cited by 315 · see citing works
Blood flow and the degree of shunting through the ductus venosus in the human fetus
Kiserud, T., Rasmussen, S., & Skulstad, S. M. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(00)70504-7 · Cited by 310 · see citing works
Drug transporters in the human blood‐placental barrier
Vähäkangas, K., & Myllynen, P. K. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00336.x · Cited by 291 · see citing works
Fetal cardiac output, distribution to the placenta and impact of placental compromise
Kiserud, T., Ebbing, C., Kessler, J., & Rasmussen, S. (2006) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.2832 · Cited by 275 · see citing works
Stewart, F. M., Freeman, D. J., Ramsay, J. E., Greer, I. A., CASLAKE, M. J., & Ferrell, W. R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2083 · Cited by 274 · see citing works
(2010) · PubMed · Cited by 249 · see citing works
Rundle, A., Hoepner, L., Hassoun, A. A., Oberfield, S. E., Freyer, G. A., Holmes, D., Reyes, M., Quinn, J. W., Camann, D., Perera, F. P., et al. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr455 · Cited by 240 · see citing works
Isoherranen, N., & Thummel, K. E. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.050245 · Cited by 239 · see citing works
Hakkola, J., Pelkonen, O., Pasanen, M., & Raunio, H. (1998) · Critical Reviews in Toxicology · doi:10.1080/10408449891344173 · Cited by 229 · see citing works
Obesity, pregnancy, inflammation, and vascular function
Denison, F. C., Roberts, K. A., Barr, S. M., & Norman, J. E. (2010) · Reproduction · doi:10.1530/rep-10-0074 · Cited by 221 · see citing works
Gómez-Roig, M. D., Pascal, R., Cahuana, M. J., García-Algar, O., Sebastiani, G., Andreu-Fernández, V., Martínez, L., Rodríguez, G., Iglesia, I., Ortiz-Arrabal, O., et al. (2021) · Fetal Diagnosis and Therapy · doi:10.1159/000514884 · Cited by 207 · see citing works
Porta, M., Puigdomènech, E., Ballester, F., Selva, J., Ribas-Fitó, N., Llop, S., & López, T. (2008) · Environment International · doi:10.1016/j.envint.2007.10.004 · Cited by 200 · see citing works
Hauser, R. B., Skakkebæk, N. E., Hass, U., Toppari, J., Juul, A., Andersson, A., Kortenkamp, A., Heindel, J. J., & Trasande, L. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4325 · Cited by 180 · see citing works
Speroff's Clinical Gynecologic Endocrinology and Infertility
Taylor, H. S., Pal, L., & Seli, E. U. (2019) · Cited by 179 · see citing works
Before the beginning: environmental exposures and reproductive and obstetrical outcomes
Segal, T. R., & Giudice, L. C. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.08.001 · Cited by 173 · see citing works
Rosenstein, M. G., Cheng, Y. W., Snowden, J. M., Nicholson, J. M., Doss, A. E., & Caughey, A. B. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.01.014 · Cited by 172 · see citing works
Sex differences in the late first trimester human placenta transcriptome
Gonzalez, T. L., Sun, T., Koeppel, A. F., Lee, B., Wang, E. T., Farber, C. R., Rich, S. S., Sundheimer, L. W., Buttle, R. A., Chen, Y.-D. I., et al. (2018) · Biology of Sex Differences · doi:10.1186/s13293-018-0165-y · Cited by 161 · see citing works
Endocrine-Disrupting Chemicals in Human Fetal Growth
Street, M. E., & Bernasconi, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041430 · Cited by 160 · see citing works
Meakin, A. S., Cuffe, J. S. M., Darby, J. R. T., Morrison, J. L., & Clifton, V. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126386 · Cited by 158 · see citing works
Gestational Diabetes Mellitus and Preeclampsia: Correlation and Influencing Factors
Yang, Y., & Wu, N. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.831297 · Cited by 155 · see citing works
Risk of Stillbirth and Infant Death Stratified by Gestational Age
Rosenstein, M. G., Cheng, Y. W., Snowden, J. M., Nicholson, J. M., & Caughey, A. B. (2012) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31825bd286 · Cited by 150 · see citing works
Gaither, K., Quraishi, A. N., & Illsley, N. P. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5438 · Cited by 149 · see citing works
Nahar, M. S., Liao, C., Kannan, K., Harris, C., & Dolinoy, D. C. (2015) · Chemosphere · doi:10.1016/j.chemosphere.2014.10.071 · Cited by 146 · see citing works
Routti, H., Atwood, T. C., Bechshøft, T., Boltunov, A. N., Ciesielski, T. M., Desforges, J.-P. W., Dietz, R., Gabrielsen, G. W., Jenssen, B. M., Letcher, R. J., et al. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.02.030 · Cited by 145 · see citing works
Polybrominated Diphenyl Ether (PBDE) Levels in Livers of U.S. Human Fetuses and Newborns
Schecter, A. J., Johnson-Welch, S. F., Tung, K. C., Harris, T. R., Päpke, O., & Rosen, R. (2006) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390600748369 · Cited by 144 · see citing works
Development of PBPK models for PFOA and PFOS for human pregnancy and lactation life stages
Loccisano, A. E., Longnecker, M. P., Campbell, J. L., Andersen, M. E., & Clewell, H. J. (2013) · Journal of Toxicology and Environmental Health, Part A · doi:10.1080/15287394.2012.722523 · Cited by 141 · see citing works
Anderson, O. S., Nahar, M. S., Faulk, C., Jones, T. R., Liao, C., Kannan, K., Weinhouse, C., Rozek, L. S., & Dolinoy, D. C. (2012) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21692 · Cited by 140 · see citing works
Cameron, N. A., Everitt, I., Seegmiller, L. E., Yee, L. M., Grobman, W. A., & Khan, S. S. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.023791 · Cited by 125 · see citing works
Walker, N., Filis, P., Soffientini, U., Bellingham, M., O’Shaughnessy, P. J., & Fowler, P. (2017) · Biology of Reproduction · doi:10.1093/biolre/iox012 · Cited by 123 · see citing works
Mamsen, L., Jönsson, B., Lindh, C. H., Olesen, R. H., Larsen, A., Ernst, E., Kelsey, T., & Andersen, C. (2017) · Science of the Total Environment · doi:10.1016/j.scitotenv.2017.04.058 · Cited by 123 · see citing works
Allopregnanolone in the brain: Protecting pregnancy and birth outcomes
Brunton, P. J., Russell, J. A., & Hirst, J. J. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.08.005 · Cited by 122 · see citing works
Endocrine-disrupting chemicals and child health
Ghassabian, A., Vandenberg, L., Kannan, K., & Trasande, L. (2022) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-021921-093352 · Cited by 112 · see citing works
Maternal BMI and gestational diabetes alter placental lipid transporters and fatty acid composition
Segura, M. T., Demmelmair, H., Krauss‐Etschmann, S., Nathan, P., Dehmel, S., Padilla, M. C., Rueda, R., Koletzko, B. V., & Campoy, C. (2017) · Placenta · doi:10.1016/j.placenta.2017.07.001 · Cited by 110 · see citing works
Prenatal phthalate exposure, infant growth, and global DNA methylation of human placenta
Zhao, Y., Shi, H., Xie, C., Chen, J., Laue, H. E., & Zhang, Y. (2014) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21916 · Cited by 107 · see citing works
Evidence that fetal death is associated with placental aging
Maiti, K., Sultana, Z., Aitken, R. J., Morris, J. M., Park, F. J., Andrew, B., Riley, S. C., & Smith, R. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.06.015 · Cited by 104 · see citing works
Yan, D., Jiao, Y., Yan, H., Liu, T., Yan, H., & Yuan, J. (2022) · Environmental Health · doi:10.1186/s12940-022-00858-8 · Cited by 104 · see citing works
Nahar, M. S., Liao, C., Kannan, K., & Dolinoy, D. C. (2012) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21459 · Cited by 100 · see citing works
Doucet, J., Tague, B., Arnold, D. L., Cooke, G. M., Hayward, S. J., & Goodyer, C. G. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.0800205 · Cited by 96 · see citing works
GC–MS analysis of bisphenol A in human placental and fetal liver samples
Zhang, J., Cooke, G. M., Curran, I. H. A., Goodyer, C. G., & Cao, X.-L. (2011) · Journal of Chromatography B · doi:10.1016/j.jchromb.2010.11.031 · Cited by 96 · see citing works
Zota, A. R., Mitro, S. D., Robinson, J. F., Hamilton, E. G., Park, J.-S., Parry, E., Zoeller, R. T., & Woodruff, T. J. (2018) · Environment International · doi:10.1016/j.envint.2017.12.030 · Cited by 95 · see citing works
Sex at the interface: the origin and impact of sex differences in the developing human placenta
Braun, A. E., Mitchel, O. R., Gonzalez, T. L., Sun, T., Flowers, A. E., Pisarska, M. D., & Winn, V. D. (2022) · Biology of Sex Differences · doi:10.1186/s13293-022-00459-7 · Cited by 94 · see citing works
Bedell, S., Hutson, J. R., de Vrijer, B., & Eastabrook, G. D. M. (2020) · Current Vascular Pharmacology · doi:10.2174/1570161118666200616144512 · Cited by 94 · see citing works
Cao, X.-L., Zhang, J., Goodyer, C. G., Hayward, S., Cooke, G. M., & Curran, I. H. A. (2012) · Chemosphere · doi:10.1016/j.chemosphere.2012.05.003 · Cited by 93 · see citing works
Domínguez-Romero, E., Komprdová, K., Kalina, J., Bessems, J., Karakitsios, S., Sarigiannis, D. A., & Scheringer, M. (2023) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/s41370-022-00441-w · Cited by 92 · see citing works
Pregnancy- associated changes in pharmacokinetics and their clinical implications
Koren, G., & Pariente, G. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2352-2 · Cited by 87 · see citing works
Argyraki, M., Damdimopoulou, P., Chatzimeletiou, K., Grimbizis, G. F., Tarlatzis, B. C., Syrrou, M., & Lambropoulos, A. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz025 · Cited by 86 · see citing works
Self-citationFlo, K., Wilsgaard, T., Vårtun, Å., & Acharya, G. (2010) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2010.02548.x · Cited by 83 · see citing works
The Stockholm classification of stillbirth
VARLI, I. H., PETERSSON, K., BOTTINGA, R., BREMME, K., HOFSJÖ, A., HOLM, M., HOLSTE, C., KUBLICKAS, M., NORMAN, M., PILO, C., et al. (2008) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1080/00016340802460271 · Cited by 83 · see citing works
Zhao, Y., Chen, J., Wang, X., Song, Q., Xu, H., & Zhang, Y. (2016) · Scientific Reports · doi:10.1038/srep33449 · Cited by 83 · see citing works
Erinc, A., Davis, M. B., Padmanabhan, V., Langen, E. S., & Goodrich, J. M. (2021) · Environmental Research · doi:10.1016/j.envres.2021.111113 · Cited by 82 · see citing works
Placental concentrations of bisphenol A and birth weight from births in the Southeastern U.S.
Troisi, J., Mikelson, C., Richards, S., Symes, S., Adair, D., Zullo, F., & Guida, M. (2014) · Placenta · doi:10.1016/j.placenta.2014.08.091 · Cited by 82 · see citing works
Fetal cells in maternal blood of pregnancies with severe fetal growth restriction
Al‐Mufti, R., LEES, C. C., Albaigés, G., et al. (2000) · Human Reproduction · doi:10.1093/humrep/15.1.218 · Cited by 76 · see citing works
Chlorinated hydrocarbon insecticides in organs of stillborn and blood of newborn babies
Curley, A., Copeland, M. F., & Kimbrough, R. D. (1969) · Archives of Environmental Health: An International Journal · doi:10.1080/00039896.1969.10666901 · Cited by 71 · see citing works
Sharma, R. P., Schuhmacher, M., & Kumar, V. (2018) · Science of The Total Environment · doi:10.1016/j.scitotenv.2017.12.023 · Cited by 68 · see citing works
Mixtures of persistent organic pollutants are found in vital organs of late gestation human fetuses
Björvang, R. D., Vinnars, M.-T., Papadogiannakis, N., Gidlöf, S., Mamsen, L. S., Mucs, D., Kiviranta, H., Rantakokko, P., Ruokojärvi, P., Lindh, C. H., et al. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.131125 · Cited by 64 · see citing works
Self-citationFaulk, C. D., Kim, J. H., Jones, T. R., McEachin, R. C., Nahar, M. S., Dolinoy, D. C., & Sartor, M. A. (2015) · Current Zoology · doi:10.1093/eep/dvv006 · Cited by 62 · see citing works
Eke, A. C., Gebreyohannes, R. D., Fernandes, M. F. S., & Pillai, V. C. (2023) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.2227 · Cited by 59 · see citing works
Bedell, S. (2021) · Current Vascular Pharmacology · doi:10.2174/18756212mta3qndapy · Cited by 57 · see citing works
Lu, G., Abduljalil, K., Jamei, M., Johnson, T. N., Soltani, H., & Rostami‐Hodjegan, A. (2012) · Current Drug Metabolism · doi:10.2174/138920012800840374 · Cited by 56 · see citing works
Szlapinski, S. K., & Hill, D. J. (2020) · Current Vascular Pharmacology · doi:10.2174/1570161118666200320111209 · Cited by 56 · see citing works
Vuong, A. M., Braun, J. M., Sjödin, A., Calafat, A. M., Yolton, K. A., Lanphear, B. P., & Chen, A. (2021) · Environment International · doi:10.1016/j.envint.2021.106747 · Cited by 54 · see citing works
Bamigboye, A. A., & Morris, J. M. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004353 · Cited by 51 · see citing works
Skakkebæk, N. E. (2016) · Hormone Research in Paediatrics · doi:10.1159/000443400 · Cited by 51 · see citing works
Differences in cytochrome p450 enzyme expression and activity in fetal and adult tissues
Robinson, J. F., Hamilton, E. G., Lam, J., Chen, H., & Woodruff, T. J. (2020) · Placenta · doi:10.1016/j.placenta.2020.07.009 · Cited by 51 · see citing works
Feto-maternal microchimerism: Memories from pregnancy
Cómitre-Mariano, B., Martínez‐Garcia, M., García-Gálvez, B., Paternina-Die, M., Desco, M., Carmona, S., & Gómez‐Gaviro, M. V. (2021) · iScience · doi:10.1016/j.isci.2021.103664 · Cited by 51 · see citing works
Pregnancy and weaning regulate human maternal liver size and function
Bartlett, A. Q., Vesco, K. K., Purnell, J. Q., Francisco, M. C., Goddard, E. T., Guan, X., DeBarber, A. E., Leo, M. C., Baetscher, E., Rooney, W. D., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2107269118 · Cited by 46 · see citing works
Biomonitoring of Human Fetal Exposure to Environmental Chemicals in Early Pregnancy
Cooke, G. M. (2014) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2014.898167 · Cited by 43 · see citing works
Fetal cardiac output and its distribution to the placenta at 11–20 weeks of gestation
Vimpeli, T., Huhtala, H., Wilsgaard, T., et al. (2008) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.6247 · Cited by 42 · see citing works
Basic Structure of the Villous Trees
Castellucci, M., & Kaufmann, P. (2006) · Springer eBooks · doi:10.1007/0-387-26742-5_6 · Cited by 42 · see citing works
Nielsen, C., Hall, U. A., Lindh, C. H., Ekström, U., Xu, Y.-Y., Li, Y., Holmäng, A., & Jakobsson, K. (2020) · Environmental Health · doi:10.1186/s12940-020-00626-6 · Cited by 39 · see citing works
Tkalec, Ž., Codling, G., Tratnik, J. S., Mazej, D., Klánová, J., Horvat, M., & Kosjek, T. (2022) · Environmental Pollution · doi:10.1016/j.envpol.2022.120091 · Cited by 39 · see citing works
Calatayud, M., García‐Barrera, T., Leblic, B. C., Arias‐Borrego, A., & Collado, M. C. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.115994 · Cited by 36 · see citing works
Pitz Jacobsen, D., Fjeldstad, H. E., Johnsen, G. M., Fosheim, I. K., Moe, K., Alnæs-Katjavivi, P., Dechend, R., Sugulle, M., & Staff, A. C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.791606 · Cited by 36 · see citing works
Endocrine-Disrupting Chemicals in Human Fetal Growth
Street, M. E., & Bernasconi, S. (2020) · Prime Archives in Molecular Biology · doi:10.37247/pamb.1.2020.42 · Cited by 35 · see citing works
Immunobiology of pregnancy: from basic science to translational medicine
Colamatteo, A., Fusco, C., Micillo, T., D’Hooghe, T., de Candia, P., Alviggi, C., Longobardi, S., & Matarese, G. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.05.009 · Cited by 32 · see citing works
Maternal cardiovascular and endothelial function from first trimester to postpartum
Kolovetsiou-Kreiner, V., Moertl, M. G., Papousek, I., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197748 · Cited by 31 · see citing works
Teulings, N. E. W. D., Wood, A. M., Sovio, U., Ozanne, S. E., Smith, G. C. S., & Aiken, C. E. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0627-2 · Cited by 30 · see citing works
Hexabromocyclododecane concentrations in Canadian human fetal liver and placental tissues
Rawn, D. F. K., Gaertner, D. W., Weber, D. F., et al. (2013) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2013.08.014 · Cited by 26 · see citing works
Vimpeli, T., Huhtala, H., Wilsgaard, T., et al. (2009) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.6354 · Cited by 26 · see citing works
Flo, K., Blix, E. S., Husebekk, A., et al. (2015) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12802 · Cited by 22 · see citing works
Chlorinated hydrocarbon insecticide content of the neonate
Zavon, M. R., Tye, R., & Latorre, L. (1969) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1969.tb15840.x · Cited by 22 · see citing works
Physiological Adaptations of Pregnancy Affecting the Nervous System
Lee, L. (2007) · Seminars in Neurology · doi:10.1055/s-2007-991124 · Cited by 22 · see citing works
Sexually Dimorphic Accumulation of Persistent Organic Pollutants in Fetuses
Björvang, R. D., & Mamsen, L. S. (2022) · Frontiers in Toxicology · doi:10.3389/ftox.2022.909307 · Cited by 19 · see citing works
Impact assessment of endocrine disruptors on sudden intrauterine and infant death syndromes
Pusiol, T., Lavezzi, A., Matturri, L., Termopoli, V., Cappiello, A., Piscioli, F., & Roncati, L. (2016) · European Journal of Forensic Sciences · doi:10.5455/ejfs.197968 · Cited by 16 · see citing works
Flo, K., Wilsgaard, T., Vårtun, Å., & Acharya, G. (2011) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000400323.42088.c2 · Cited by 15 · see citing works
Moscovitz, J. E., Nahar, M. S., Shalat, S. L., Slitt, A. L., Dolinoy, D. C., & Aleksunes, L. M. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.068668 · Cited by 12 · see citing works
The Hepatobiliary System: An Overview of Normal Function and Diagnostic Testing in Pregnancy
Gonzalez-Brown, V. M., & Frey, H. A. (2019) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000504 · Cited by 8 · see citing works
Yarlagadda, R. D., Johnson, J., Vårtun, Å., Flo, K., & Acharya, G. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-03824-3 · Cited by 6 · see citing works
Stefopoulou, M., Johnson, J., Herling, L., et al. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.658502 · Cited by 6 · see citing works
Yan, D., Jiao, Y., Yan, H., Liu, T., Yan, H., & Yuan, J. (2021) · Research Square · doi:10.21203/rs.3.rs-1077258/v1 · Cited by 2 · see citing works
Vuong, A. M., Braun, J. M., Sjödin, A., Calafat, A. M., Yolton, K. A., Lanphear, B. P., & Chen, A. (2021) · ISEE Conference Abstracts · doi:10.1289/isee.2021.p-700 · Cited by 1
Romero, E. D., Komprdová, K., Kalina, J., Bessems, J., Karakitsios, S., Sarigiannis, D. A., & Scheringer, M. (2022) · Toxicology Letters · doi:10.1016/j.toxlet.2022.07.378
Flagged first, then by citations
Research works printed but not linked: 1
- Nishimura, 1977, Levels of polychlorinated biphenyls and organochlorine insecticides in human embryos and fetuses, Paediatrician, 6
Cited by
Sorted by citations
Endocrine-disrupting chemicals and female reproductive health: a growing concern
Parent, A., Damdimopoulou, P., Johansson, H. K. L., Bouftas, N., Draskau, M. K., Franssen, D., Fudvoye, J., van Duursen, M. B. M., & Svingen, T. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01131-x · Cited by 71 · see citing works
Self-citationEndocrine disrupting chemicals are a threat to hormone health: a commentary on behalf of the ESE
Reincke, M., Arlt, W., Damdimopoulou, P., Köhrle, J., & Bertherat, J. Y. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-00958-0 · Cited by 32 · see citing works
Self-citationAl‐Maqtari, Q. A., Mahdi, A. A., Othman, N., Noman, A. E., Alsubhi, L. M., AL‐Ansi, W., Asharuddin, S. M., Talib, M. K. M., Supramanium, S., & Al-Gheethi, A. A. S. (2025) · Results in Engineering · doi:10.1016/j.rineng.2025.107169 · Cited by 31 · see citing works
Tanui, I. C., Kandie, F. J., Krauss, M. K. V., Piotrowska, A., Finckh, S., Kiprop, A. K., Hollert, H., Shahid, N., Liess, M., & Brack, W. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.125623 · Cited by 20 · see citing works
Al‐Saleh, I., Aljerayed, Y., Gheith, M., Alobaid, N. K., Alenazi, H., Elkhatib, R., Aldhalaan, H., Alnemer, M., Mohamed, G., & Shoukri, M. M. (2025) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2025.114647 · Cited by 12 · see citing works
Huo, Y., Wan, Y., Li, Y., Lan, L., Chen, S., Xu, S., Xiong, C., & Xia, W. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.172723 · Cited by 9 · see citing works
Nanoparticles in Hormonal Regulation of the Female Reproductive System
Vijayakumar, V., Rathinam, T., Deenadhayalan, S. S., Edwin, E. R., Harikrishnan, P., & Balaji, P. (2024) · Journal of Bio-X Research · doi:10.34133/jbioxresearch.0027 · Cited by 9 · see citing works
Zhang, J.-J., Chen, Y.-K., Chen, Y.-Q., Zhang, Q.-Y., Liu, Y., Wang, Q., & Xie, X. (2025) · Toxics · doi:10.3390/toxics13080617 · Cited by 7 · see citing works
Acharya, B., Behera, A., Sahu, P. K., Chowdhury, B., & Behera, S. (2024) · Advances in Bamboo Science · doi:10.1016/j.bamboo.2024.100074 · Cited by 7 · see citing works
Awada, C., Saporito, A. F., Zelikoff, J. T., & Klein, C. B. (2024) · Genes · doi:10.3390/genes15030322 · Cited by 7 · see citing works
Vaknine, S., Lobmaier, S. M., Sharma, R., Madrer, N., Dubnov, S., Shulman, D., Greenberg, P., Bennett, E. R., Greenberg, D., Turjeman, ., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03011-2 · Cited by 9 · see citing works
Xie, G., Zhou, Y., Zheng, Q., Wang, L., Wang, Y., Zeng, H., Wang, J., & Li, X. (2025) · Reproductive Toxicology · doi:10.1016/j.reprotox.2025.108948 · Cited by 5 · see citing works
Knox, B., Güil-Oumrait, N., Midya, V., Vespalcová, H., Gómez-Roig, M. D., Llurba, E., Márquez, S., Ruiz, Z. G., Galmés, T., Philippat, C., et al. (2026) · Environmental Science & Technology · doi:10.1021/acs.est.5c13234 · Cited by 5 · see citing works
Nirenjen, S., Singh, S. A., Begum, R. F., Arun, E., Vellapandian, C., & Narayanan, J. (2025) · Journal of Endocrinology · doi:10.1530/joe-24-0374 · Cited by 5 · see citing works
Goodman, C. V., Till, C., Berghuis, S. A., Braun, J. M., Muckle, G., Chen, A., Oulhote, Y., Lanphear, B. P., Ashley‐Martin, J., & Arbuckle, T. E. (2025) · Environment International · doi:10.1016/j.envint.2025.109701 · Cited by 4 · see citing works
The Role of Oxytocin in Parental Care
Yuan, Y., Gao, Z., & Xiao, W. (2025) · Endocrinology · doi:10.1210/endocr/bqaf129 · Cited by 3 · see citing works
Higher PFOS exposure associated with higher SHBG in third trimester. The Odense Child Cohort
Jensen, R. C., Glintborg, D., Batzella, E., Nielsen, F., Boye, H., Schmedes, A., Jensen, T. K., & Andersen, M. (2025) · Environmental Research · doi:10.1016/j.envres.2025.121265 · Cited by 3 · see citing works
Gestational diabetes and its effect on fetal thymus size: a case–control study
Mansouri, N., Khezripour, E., Rashtiani, N., et al. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-07468-5 · Cited by 2 · see citing works
Li, K., Zhao, X., Xie, Z., Wu, Q., Jia, W., Zhou, X., Gao, X., Zeng, P., Li, J., Niu, Q., et al. (2026) · Communications Biology · doi:10.1038/s42003-026-09697-6 · Cited by 2 · see citing works
Mother, placenta, and fetal health: Endocrine disrupting chemicals at play
Padmanabhan, V., & Veiga‐Lopez, A. (2023) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2023.112100 · Cited by 2 · see citing works
Khoshkerdar, A., Eid, N., Batra, V., Baker, N., Holmes, N., Henson, S., Sang, F., Wright, V. J., McLaren, J., Shakesheff, K. M., et al. (2024) · Nutrients · doi:10.3390/nu16121879 · Cited by 2 · see citing works
Maternal and cord blood levels of metals and fetal liver function
Ma, H., Mustafa, M. A., Maashi, M. S., Menon, S. V., Sivaprasad, G. V., Hjazi, A. M., Ibrahim, F. M., Jabbar, H. S., & Meng, X. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.125305 · Cited by 2 · see citing works
García-Martínez, Y., Razo-Estrada, A. C., Pérez-Pastén-Borja, R., Galván-Colorado, C., Chamorro, G., Chanona‐Pérez, J. J., López-Canales, O. A., Islas‐Flores, H., Pérez‐Gutiérrez, S., Cordero‐Martínez, J., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18010101 · Cited by 2 · see citing works
Wei, J., Fu, D., Guo, S., Tian, T., Huang, Y., Li, Z., Wang, L., Jin, L., Ye, W., Ren, A., et al. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.125037 · Cited by 1 · see citing works
The metabolic implications of maternal exercise: effects on pregnant women and their offspring
He, Z., Yuan, Y., Zhang, L. Y., Niu, W., Liu, L., Chen, B., & Wang, X. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1741714 · Cited by 1 · see citing works
Xie, K., Tian, H., Xiao, X., et al. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.119844 · Cited by 1 · see citing works
Ganamurali, N., Devarajan, M., & Sabarathinam, S. (2026) · Comprehensive physiology · doi:10.1002/cph4.70138
Palaniswamy, S., Přibylová, P., Kukučka, P., Laatio, L., Sieppi, E., Kummu, M., Myllynen, P. K., & Abass, K. M. (2026) · Exposure and Health · doi:10.1007/s12403-026-00773-0
Ahmadian-Moghadam, S., Roshan‐Milani, S., & Saboory, E. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04151-x
Panneerselvam, D., Murugesan, A., Kumar, J. S., & Preethika, A. (2026) · Endocrine · doi:10.1007/s12020-026-04708-2
Yakhlef, M., Aissani, F., Ayeche, R., Aggoune, N. E. I., Bouamine, S., & Boudalia, S. (2026) · Al-Rafidain Journal of Medical Sciences · doi:10.54133/ajms.v11i1.3104
Natarajan, N., Venkatesan, S., & Arulappan, J. (2026) · Research Square · doi:10.21203/rs.3.rs-10857622/v1
- Authors
- Vinnars, M.-T., Bixo, M., & Damdimopoulou, P.
- Affiliations
- Umeå University (SE)
- Karolinska University Hospital (SE)
- Corresponding author
- Damdimopoulou, Pauliina
- Venue
- Molecular and Cellular Endocrinology
- Publisher
- Elsevier BV
- Published
- 2023-12
- Volume
- 578
- Pages
- 112064
- ISSN
- 0303-7207 (ISSN-L)
- OpenAlex
- W4386470738
- Semantic Scholar
- e76e253785f99f1ba2c00bf9e98c33084d0c7f66
- Cited by
- 32
- References
- 110
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 9 · 2023: 1
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Molecular and Cellular Endocrinology (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DiVA at Umeå University (Umeå University) (submittedVersion, other-oa)
- Funders
- European Commission (HORIZON2020, 952516)
- Svenska Forskningsrådet Formas
- Karolinska Institutet
- Vetenskapsrådet (2020-01621, 2018-)
- Topics
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Health, Environment, Cognitive Aging
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- pregnancy, placental function, pregnancy complications, fetal sex differences, fetal organ development, prenatal exposure
- MeSH terms
- Adaptation, Physiological, Animals, Female, Fetus, Humans, Maternal-Fetal Exchange, Placenta, Pregnancy, Maternal Exposure, Fetal Development
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-23.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-23.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review